Skip to main content

June 10: VDP Formulary, CAD, MCO Search Realignment Now Active

Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

4. References

  1. Department of Justice. Drug Enforcement Administration. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Fed Regist. 2014;79(163):49661-82.
  2. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2021. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed November 29, 2023.
  3. Cofano S, Yellon R. Hydrocodone. PubMed. Published October 24, 2022. https://www.ncbi.nlm.nih.gov/books/NBK537288/.
  4. Hydrocodone bitartrate/ acetaminophen oral tablets package insert. Amneal Pharmaceuticals, LLC. December 2021.
  5. Hydrocodone bitartrate/ acetaminophen oral solution package insert. Eywa Pharma, Inc, October 2022.
  6. Hydrocodone bitartrate/ ibuprofen oral tablets package insert. Amneal Pharmaceuticals of New York, LLC, November 2022.
  7. Hydrocodone polistirex and chlorpheniramine polistirex suspension, extended-release package insert. Neos Therapeutics, LP. June 2020.
  8. Hydrocodone bitartrate extended-release tablets (Hysingla ER) package insert. Purdue Pharma LLP, March 2021.
  9. Hydrocodone bitartrate capsule, extended-release package insert. Alvogen Inc., March 2021.
  10. Hydrocodone bitartrate and homatropine methylbromide oral solution liquid package insert. KVK-Tech, Inc., December 2018.
  11. U.S. Food and Drug Administration FDA News Release. FDA acts to protect kids from serious risks of opioid ingredients contained in some prescription cough and cold products by revising labeling to limit pediatric use. January 2018.
  12. Naloxone hydrochloride (Narcan) 4 mg/ 0.1 mL nasal spray package insert. Emergent Devices Inc., August 2023.
  13. Naloxone hydrochloride (Kloxxado) 8 mg/ 0.1 mL nasal spray package insert. Hikma Specialty USA Inc., May 2022.
  14. Naloxone hydrochloride (Zimhi) 5 mg/ 0.5 mL single-dose pre-filled syringe package insert. USWM, LLC. October 2021.
  15. U.S. Food and Drug Administration. FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. FDA Drug Safety Communication. Published online July 23, 2020. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-health-care-professionals-discuss-naloxone-all-patients-when-prescribing-opioid-pain. Accessed November 29th, 2023.
  16. Texas Pharmacy Association. Texas pharmacist naloxone standing order application. October 2016. Available at: https://www.texaspharmacy.org/page/TXPHARMNALOX. Accessed November 29th, 2023.
  17. Homsi J, Walsh D, Nelson KA, et al. A phase II study of hydrocodone for cough in advanced cancer. Am J Hospice Palliat Med. 2002;19(1):49-56.